TOPLINE: Dolutegravir plus lamivudine demonstrates noninferiority to the standard-of-care three-drug regimen in treatment-naive patients with HIV without preliminary drug resistance testing. METHODOLOGY: Researchers conducted a randomized, noninferiority, phase 4 trial to evaluate the efficacy and safety of dolutegravir plus lamivudine in untreated patients with HIV with no preliminary drug resistance testing. Overall, 223 participants (median […]
The post Two-Drug HIV Therapy Effective Without Resistance Testing first appeared on News Health.
Author : News Health
Publish date : 2025-03-17 05:55:00
Copyright for syndicated content belongs to the linked Source.